- Advanced search
- Immuno Portal
- Malaria Portal
AlprolixTM is an approved drug (FDA (2014))
Compound class: Peptide or derivative
Comment: AlprolixTM is a recombinant fusion protein combining the peptide for coagulation factor IX with an antibody Fc domain. The presence of the Fc domain increases protein half-life and extends the drug's therapeutic window.